✦ LIBER ✦

Sa1030 Incidence Rate and Predictors of de novo Overt Hepatocellular Carcinoma in Cirrhotic Patients Awaiting Liver Transplantation

✍ Scribed by Machicado, Jorge D.; Batra, Sachin; Dasher, Kevin; Pan, Jen-Jung; Bynon, Steve; Fallon, Michael B.; Machicao, Victor I.

Book ID: 122307246
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 144 KB
Volume: 146
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(14)63421-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Frequency and predictors of de novo hepa

Frequency and predictors of de novo hepatocellular carcinoma in patients awaiting orthotopic liver transplantation during the model for end-stage liver disease era

✍ Carla W. Brady; Alastair D. Smith; Karen M. Stechuchak; Cynthia J. Coffman; Jane 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 1 views

In the current system of allocation, patients awaiting orthotopic liver transplantation (OLT) remain at risk of developing de novo hepatocellular carcinoma (HCC) and removal from the waiting list. Using the United Network for Organ Sharing database, we calculated the rate and identified predictors o

Increased incidence of HFE C282Y mutatio

Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver

✍ Jean-Frédéric Blanc; Victor De Ledinghen; Pierre-Henri Bernard; Hubert de Verneu 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 676 KB

The development of de novo hepatocellula

The development of de novo hepatocellular carcinoma in patients on a liver transplant list: Frequency, size, and assessment of current screening methods

✍ David H. Van Thiel; Sherri Yong; S. David Li; Marc Kennedy; John Brems 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

Chronic end stage liver disease is the most frequent indication for liver transplantation. Individuals with end stage cirrhosis, and therefore individuals on liver transplant lists, are at increased risk of developing a hepatic cancer. Those individuals on liver transplant lists also may represent t